In a recent study published in PLoS Computational Biology, researchers used mathematical modelling to evaluate whether prioritizing older individuals for coronavirus disease 2019 (COVID-19) booster vaccinations consistently leads to optimal public health outcomes across diverse socio-economic settings.
In the early stages of the COVID-19 pandemic, non-pharmaceutical interventions (NPIs) were crucial in reducing transmission and protecting healthcare systems.
The introduction of vaccines, such as those from Pfizer-BioNTech, Oxford-AstraZeneca, and Moderna, significantly altered the pandemic’s trajectory by reducing severe cases and relaxing NPIs.
However, immunity from these vaccines wanes over time, necessitating booster vaccinations, especially with emerging variants.
Further research is needed to refine booster vaccination strategies to address varying population structures and socio-economic contexts globally, ensuring the most effective public health outcomes.
About the study
The study extends a previously published age-structured compartmental model of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission and vaccination.
This deterministic model, governed by ordinary differential equations, divides individuals into compartments based on age, current infection status, and immune status before any infection.
The model includes 16 age groups, with individuals classified as Susceptible, Exposed, Infectious (symptomatic or asymptomatic), or Recovered.
To more accurately represent the time spent in the exposed class, the model employs gamma distributions, which provide a realistic representation of epidemiological periods.
The model also tracks immune status, categorizing individuals into groups such as Vaccinated, Boosted, Partially Waned, Fully Waned, and Unvaccinated, reflecting their infection and vaccination history.
The effectiveness of vaccination is incorporated into the model, accounting for reduced risks of infection, symptoms, hospitalization, and death.
Using this model, the study examines the impacts of six different age-based booster vaccination strategies across eight countries. Strategy 1 prioritizes the oldest individuals first, while Strategy 6 explores vaccinating those with the most contacts to provide indirect protection to the elderly.
Strategies 2-5 test variations of these approaches, generally focusing on prioritizing older individuals for booster vaccination. The analysis assumes limited vaccine availability, with a 10% population coverage baseline and a 90% maximum uptake per age group.
Study results
The population’s age structure varies significantly across countries, with high-income countries generally having a larger proportion of older individuals compared to low-income countries.
This demographic difference influences the distribution of booster vaccines under different vaccination strategies. In the UK, for instance, strategies 1-4 that prioritize older individuals for booster vaccination result in a substantial number of individuals aged 50-74 receiving vaccines. However, the oldest individuals (75+) may not be fully covered due to the limited vaccine supply.
On the other hand, Strategies focused on vaccinating younger individuals, particularly those aged 20-49, who typically have more contacts and, therefore, could potentially contribute to indirect protection of older populations.
However, the age distribution of vaccinated individuals under each strategy varies between countries. For example, in Sierra Leone, where the proportion of older individuals is relatively small, Strategies 1-4 effectively vaccinate almost all older individuals, leading to identical outcomes for these strategies.
This contrasts with the situation in the UK, where a larger elderly population means that not all older individuals can be vaccinated under these strategies due to vaccine constraints.
When considering the impact of these strategies on public health outcomes during a wave of infections caused by a novel SARS-CoV-2 variant, the model projections indicated that Strategy 1 consistently resulted in the fewest deaths across all countries analyzed.
This outcome is particularly evident in high-income countries, where a large proportion of older individuals contribute to a higher projected number of deaths if they are not prioritized for booster vaccination.
In contrast, in countries like Sierra Leone, the small number of older individuals allows nearly all of them to receive booster vaccines under Strategy 1, leading to fewer deaths overall.
The analysis also examined the projected Years of Life Lost (YLL), which accounts for the number of deaths and the ages at which they occur.
While it might be expected that vaccinating younger individuals could reduce YLL, the model consistently showed that Strategy 1, which prioritizes the oldest individuals, was optimal in minimizing YLL. This is due to the higher risk of severe outcomes and mortality associated with SARS-CoV-2 infection in older populations.
Sensitivity analyses further supported these findings, showing that Strategy 1 led to fewer deaths and YLL under various assumptions, including different levels of vaccine availability, uptake rates, and timing of booster administration.
Even when the outbreak began 150 days after booster vaccines were administered, resulting in some immunity waning, Strategy 1 remained the most effective approach in reducing deaths and YLL.
Conclusions
To summarize, future SARS-CoV-2 transmission will be influenced by novel variants, booster vaccinations, and immunity dynamics. Unlike the pandemic’s early stages, many individuals globally are now infected or vaccinated, impacting immunity and transmission.
In this evolving scenario, it is essential to reassess the effectiveness of past interventions and explore new strategies.
This study evaluated different age-based booster vaccination strategies and found that prioritizing older individuals consistently leads to better public health outcomes, regardless of varying population structures.
- Bouros I, Hill EM, Keeling MJ, et al. (2024) Prioritizing older individuals for COVID-19 booster vaccination leads to optimal public health outcomes in a range of socio-economic settings. PLoS Comput Biol. doi:https://doi.org/10.1371/journal. pcbi.1012309. https://journals.plos.org/ploscompbiol/article?
News
Your Washing Machine Might Be Helping Antibiotic-Resistant Bacteria Spread
A new study reveals that biofilms in washing machines may contain potential pathogens and antibiotic resistance genes, posing possible risks for laundering healthcare workers’ uniforms at home. Washing healthcare uniforms at home could be [...]
Scientists Discover Hidden Cause of Alzheimer’s Hiding in Plain Sight
Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help treat the disease early by targeting the gene’s hidden function. A recent study has revealed that a gene previously [...]
How Brain Cells Talk: Inside the Complex Language of the Human Mind
Introduction The human brain contains nearly 86 billion neurons, constantly exchanging messages like an immense social media network, but neurons do not work alone – glial cells, neurotransmitters, receptors, and other molecules form a vast [...]
Oxford study reveals how COVID-19 vaccines prevent severe illness
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated. Despite the global success of [...]
Annual blood test could detect cancer earlier and save lives
A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart progression to advanced disease while the malignancy is still at an early [...]
How the FDA opens the door to risky chemicals in America’s food supply
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are [...]
Superbug crisis could get worse, killing nearly 40 million people by 2050
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them could increase nearly 70% by 2050, a new study projects, further showing the [...]
How Can Nanomaterials Be Programmed for Different Applications?
Nanomaterials are no longer just small—they are becoming smart. Across fields like medicine, electronics, energy, and materials science, researchers are now programming nanomaterials to behave in intentional, responsive ways. These advanced materials are designed [...]
Microplastics Are Invading Our Arteries, and It Could Be Increasing Your Risk of Stroke
Higher levels of micronanoplastics were found in carotid artery plaque, especially in people with stroke symptoms, suggesting a potential new risk factor. People with plaque buildup in the arteries of their neck have been [...]
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging [...]
Engineered extracellular vesicles facilitate delivery of advanced medicines
Graphic abstract of the development of VEDIC and VFIC systems for high efficiency intracellular protein delivery in vitro and in vivo. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59377-y. https://www.nature.com/articles/s41467-025-59377-y Researchers at Karolinska Institutet have developed a technique [...]
Brain-computer interface allows paralyzed users to customize their sense of touch
University of Pittsburgh School of Medicine scientists are one step closer to developing a brain-computer interface, or BCI, that allows people with tetraplegia to restore their lost sense of touch. While exploring a digitally [...]
Scientists Flip a Gut Virus “Kill Switch” – Expose a Hidden Threat in Antibiotic Treatment
Scientists have long known that bacteriophages, viruses that infect bacteria, live in our gut, but exactly what they do has remained elusive. Researchers developed a clever mouse model that can temporarily eliminate these phages [...]
Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressing
Background Wound healing is a complex physiological process that can be compromised by infection and impaired tissue regeneration. Conventional dressings, typically made from natural fibers such as cotton or linen, offer limited functionality. Nanofiber [...]
Global Nanomaterial Regulation: A Country-by-Country Comparison
Nanomaterials are materials with at least one dimension smaller than 100 nanometres (about 100,000 times thinner than a human hair). Because of their tiny size, they have unique properties that can be useful in [...]
Pandemic Potential: Scientists Discover 3 Hotspots of Deadly Emerging Disease in the US
Virginia Tech researchers discovered six new rodent carriers of hantavirus and identified U.S. hotspots, highlighting the virus’s adaptability and the impact of climate and ecology on its spread. Hantavirus recently drew public attention following reports [...]
